NbN C&A 3.1.1

European College of Neuropsychopharmacology (ECNP) ❘ Freeware ❘
iOS

Laatste versie
3.1.1 Veilig te installeren

Report a Problem

Dit is geen downloadformulier!

De UpdateStar programma database wordt bijgehouden door gebruikers, voor gebruikers.
Met uw steun kunt u helpen om de software van alle andere gebruikers actueel te houden. Vul alle velden in die onjuist of achterhaald zijn. We zullen uw bijdrage zo spoedig mogelijk controleren en beoordelen.
Wij danken u voor uw steun aan UpdateStar!

Titel:

Categorie:

Vereisten:

Android

iOS

Windows

Mac

Linux

Licentie:

Uitgever:

Uitgever URL:

Beschrijving:

The NbN was developed in response to the recognition that the existing pharmacological nomenclature for psychotropic medications does not adequately reflect current scientific understanding nor support clinicians in neuroscience-informed prescribing practices. Frequently, clinicians prescribe "antidepressants" for anxiety disorders or "second-generation antipsychotics" for depression, which can lead to confusion and a lack of clarity regarding the underlying mechanisms involved.

The primary objective of NbN is to integrate recent advances in neuroscience into the terminology used for psychotropic medications. Its scope encompasses all drugs with central nervous system (CNS) indications, aiming to facilitate clinicians' identification of the most appropriate subsequent neuropsychopharmacological interventions based on a more precise understanding of drug action.

This proposed nomenclature endeavors to accurately reflect the current state of pharmacological knowledge; however, it acknowledges that it may not represent the definitive scientific consensus. The assembled taskforce deliberately chose to present a scientific interpretation rooted in the latest evidence rather than await absolute conclusions. This approach recognizes the urgent need for effective treatment in clinical settings, emphasizing that patient care cannot be delayed pending complete scientific certainty.

Consequently, this nomenclature is founded upon key considerations:
<ul>
<li>The imperative to treat patients promptly</li>
<li>The integration of contemporary neuroscience insights</li>
<li>The expert judgment of taskforce members</li>
<li>Recognition that pediatric populations are still developing, thus developmental factors such as hepatic and renal function and brain maturation must influence medication use and dosing</li>
</ul>

In developing NbN, emphasis has been placed on pharmacology and mechanisms of action. The nomenclature reflects current understanding of neurotransmitter systems, molecular targets, and pathways involved in psychotropic drug effects. Four clinically pertinent dimensions are incorporated:
<ol>
<li>Approved indications: Based on major regulatory bodies’ recommendations (e.g., FDA, EMA) applicable to specific age groups.</li>
<li>Efficacy and side effects: Highlighting instances where drugs lack formal approval for certain indications but are supported by evidence such as expert guidelines. The side effects section focuses on serious, life-threatening, or prevalent adverse effects.</li>
<li>Practical notes: Summarized clinical insights filtered through expert analysis.</li>
<li>Neurobiology: Derived from empirical data, providing a biological context for the medication’s action.</li>
</ol>

For those interested in further details regarding pharmacology, a direct link to the IUPHAR website—our collaborating partner—is provided for in-depth information.

This initiative is ongoing; we anticipate that gaps and omissions will be identified over time. Feedback from users, combined with responses from colleagues, emerging research reports, and new scientific findings, will inform subsequent updates to enhance the nomenclature’s accuracy and utility.

FiN N aims to embed cutting-edge neuroscience within a coherent and comprehensive naming framework for pediatric psychopharmacology. The taskforce hopes this system will support clinicians in making well-informed decisions regarding psychopharmacological treatment strategies and elucidate the rationale behind prescribing choices.

Labels:

Korte beschrijving:

Geïnstalleerde versie onbekend?

Huidige versie:

Download URL:

Directe download URL:

Koop URL:

Pictogram URL:

Schermafbeelding 1 URL:

Schermafbeelding 2 URL:

Schermafbeelding 3 URL:

Schermafbeelding 4 URL:

PAD-bestand URL:

Opmerking:

Uw e-mailadres:

Nieuwsbrief:

Voer uw e-mailadres in zodat wij u kunnen bereiken indien we vragen hebben over uw bijdrage. Wij zullen uw e-mailadres nooit delen met derden.

Schermafbeeldingen (Klik om te vergroten)

Aanverwant

Veilige en gratis downloads, gecontroleerd door UpdateStar

Blijf actueel
met UpdateStar freeware.

Recente beoordelingen

	Logitech G HUB Til je game-ervaring naar een hoger niveau met Logitech G HUB
	Zoom Workplace (32-bit) Zoom Workplace: AI-first uniforme samenwerking voor hybride teams
	Autodesk Featured Apps Geef uw creativiteit de vrije loop met Autodesk Featured Apps!
	Kaspersky Password Manager Beveilig je wachtwoorden met Kaspersky Password Manager!
	Revo Uninstaller Zeg vaarwel tegen hardnekkige software met Revo Uninstaller!
	EASEUS Partition Master Home Edition EASEUS Partition Master Home Edition: efficiënte software voor partitiebeheer

Meest populaire downloads

	UpdateStar Premium Edition Uw software up-to-date houden is nog nooit zo eenvoudig geweest met UpdateStar Premium Edition!
	Google Chrome Snelle en veelzijdige webbrowser
	Microsoft Edge Een nieuwe standaard in surfen op het web
	Microsoft Visual C++ 2015 Redistributable Package Verbeter de prestaties van uw systeem met Microsoft Visual C++ 2015 Redistributable Package!
	Microsoft OneDrive Stroomlijn uw bestandsbeheer met Microsoft OneDrive
	Microsoft Visual C++ 2010 Redistributable Essentieel onderdeel voor het uitvoeren van Visual C++-toepassingen